Yuning X. Liao

Guangdong Provincial Key Laboratory Of Protein Modification And Disease
Guangzhou, 511436, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications

The GCN5L2-SIX1 complex drives glycolysis to promote progression of triple-negative breast cancer.

The GCN5L2-SIX1 complex drives glycolysis to promote progression of triple-negative breast cancer.

Journal: Cancer letters
Published: February 27, 2026

Saquinavir induces pyroptosis through the OTUD5-JAK1-GSDME axis in hepatocellular carcinoma.

Saquinavir induces pyroptosis through the OTUD5-JAK1-GSDME axis in hepatocellular carcinoma.

Journal: Free radical biology & medicine
Published: December 16, 2025

The RPS15-DDX21 complex drives prostate malignancy through transcriptional activation of SCD1.

The RPS15-DDX21 complex drives prostate malignancy through transcriptional activation of SCD1.

Journal: Oncogene
Published: November 06, 2025

CAND1 mediates CUL7-dependent HER2 protein stability to drive breast cancer progression.

CAND1 mediates CUL7-dependent HER2 protein stability to drive breast cancer progression.

Journal: Breast cancer research : BCR
Published: March 19, 2025

WBP11 inhibits UFL1-mediated UFMylation of NONO to drive hepatocellular carcinoma progression.

WBP11 inhibits UFL1-mediated UFMylation of NONO to drive hepatocellular carcinoma progression.

Journal: Oncogene
Published: February 26, 2025

Ku70 targets BRD3-MYC/Cyclin D1 axis to drive hepatocellular carcinoma progression.

Ku70 targets BRD3-MYC/Cyclin D1 axis to drive hepatocellular carcinoma progression.

Journal: Experimental cell research
Published: September 27, 2024

METTL14-mediated m6A modification enhances USP22-ERα axis to drive breast cancer malignancy.

METTL14-mediated m6A modification enhances USP22-ERα axis to drive breast cancer malignancy.

Journal: Pharmacological research
Published: September 21, 2024

SENP3 mediates deSUMOylation of SIX1 to promote prostate cancer proliferation and migration.

SENP3 mediates deSUMOylation of SIX1 to promote prostate cancer proliferation and migration.

Journal: Cellular & molecular biology letters
Published: April 11, 2024

HSP90β Impedes STUB1-Induced Ubiquitination of YTHDF2 to Drive Sorafenib Resistance in Hepatocellular Carcinoma.

HSP90β Impedes STUB1-Induced Ubiquitination of YTHDF2 to Drive Sorafenib Resistance in Hepatocellular Carcinoma.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 29, 2023

Neddylation of HER2 Inhibits its Protein Degradation and promotes Breast Cancer Progression.

Neddylation of HER2 Inhibits its Protein Degradation and promotes Breast Cancer Progression.

Journal: International journal of biological sciences
Published: June 06, 2022

A SIX1 degradation inducer blocks excessive proliferation of prostate cancer.

A SIX1 degradation inducer blocks excessive proliferation of prostate cancer.

Journal: International journal of biological sciences
Published: October 08, 2021

Bilirubin Restrains the Anticancer Effect of Vemurafenib on BRAF-Mutant Melanoma Cells Through ERK-MNK1 Signaling.

Bilirubin Restrains the Anticancer Effect of Vemurafenib on BRAF-Mutant Melanoma Cells Through ERK-MNK1 Signaling.

Journal: Frontiers in oncology
Published: April 22, 2021
Showing 1-12 of 40

Last Updated: 09/26/2026